✦ LIBER ✦

Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study

✍ Scribed by Harry J. Long III; Bradley J. Monk; Helen Q. Huang; Edward C. Grendys Jr.; D. Scott McMeekin; Joel Sorosky; David S. Miller; Lynne A. Eaton; James V. Fiorica

Book ID: 113960275
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 295 KB
Volume: 100
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2005.09.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of the combination of bry

Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study

✍ Farr Nezhat; Scott Wadler; Franco Muggia; John Mandeli; Gary Goldberg; Jamal Rah 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Combination of Ifosfamide, Paclitaxel, a

Combination of Ifosfamide, Paclitaxel, and Cisplatin for the Treatment of Metastatic and Recurrent Carcinoma of the Uterine Cervix: A Phase II Study of the Hellenic Cooperative Oncology Group

✍ Meletios A. Dimopoulos; Christos A. Papadimitriou; Kyrillos Sarris; Gerassimos A 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Phase II study of mitomycin-C and cispla

Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study

✍ H.C. Wagenaar; S. Pecorelli; C. Mangioni; M.E.L. van der Burg; N. Rotmensz; A. A 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 96 KB

The combination of cisplatin, doxorubici

The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma: A phase II randomized trial of the Italian oncology group for clinical research

✍ Vincenzo De Lisi; Giorgio Cocconi; Francesco Angelini; Francesco Cavicchi; Franc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 2 views

## BACKGROUND. In a randomized Phase I1 study, the authors evaluated the activity and toxicity of the new cisplatin, doxorubicin, and mitomycin C (PAM) comhination, that includes cisplatin (P) instead of 5-fluorouracil as in the 5-fluorouracil, doxorubicin, and mitomycin C (FAM) Combination, in pat

All-trans retinoic acid and interferon-α

All-trans retinoic acid and interferon-α-2a in patients with metastatic or recurrent carcinoma of the uterine cervix : Clinical and pharmacokinetic studies

✍ Scott Wadler; Edward L. Schwartz; Hilda Haynes; Ronalde Rameau; Astrid Quish; Jo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

## Background: Recent clinical trials with a combination of interferon (ifn alpha) and 13 cis-retinoic acid resulted in high response rates among women with locally advanced and metastatic carcinoma of the uterine cervix. the authors sought to amplify these observations by employing the isomer of 1